Startseite Naturwissenschaften The crystal structure of (1Z, 2Z)-3-phenyl-2-propenal 2-(4-bromo-2-fluorophenyl)hydrazone, C15H12BrFN2
Artikel Open Access

The crystal structure of (1Z, 2Z)-3-phenyl-2-propenal 2-(4-bromo-2-fluorophenyl)hydrazone, C15H12BrFN2

  • Shanshan Yang ORCID logo , Zhuyun Liu ORCID logo , Yunying Sha , Weiting Yan , Weilu Guo , Lei Wang , Lizhong Wang und Pengfei Ding ORCID logo EMAIL logo
Veröffentlicht/Copyright: 23. Oktober 2025

Abstract

C15H12BrFN2, monoclinic, P21/c (no. 14), a = 9.9691(3) Å, b = 23.3493(6) Å, c = 12.1273(4) Å, β = 102.534(3)°, V = 2755.61(15) Å3, Z = 8, Rgt(F) = 0.0387, wRref(F2) = 0.1145, T = 293(2) K.

CCDC no.: 2413957

1 Source of materials

Dissolve 4-bromo-2-fluorophenylhydrazine hydrochloride (1.449 g, 6 mmol) in 30 mL of ethanol and stir at room temperature until it is dissolved. Subsequently, cinnamaldehyde (0.661 g, 5 mmol) was added dropwise to the above solution and the reaction was continued under the same conditions. After monitoring the reaction by TLC, add 30 mL of water to the reaction solution and extract the target compound with ethyl acetate (50 mL × 3). Then dry the combined organic phases overnight with Na2SO4 and remove the solvent by vacuum distillation. The residue was recrystallized from ethanol to obtain (1Z, 2Z)-3-phenyl-2-propenal 2-(4-bromo-2-fluorophenyl)hydrazone yellow flocculent crystals 1 (Table 1).

Table 1:

Data collection and handling.

Crystal: Clear light colourless block
Size: 0.15 × 0.12 × 0.10 mm
Wavelength: CuKα radiation (1.54184 Å)
μ: 4.07 mm−1
Diffractometer, scan mode: XtaLAB Synergy, Rigaku, ω scans
θmax, completeness: 66.6°, 99 %
N(hkl)measured, N(hkl)unique, Rint: 25193, 4837, 0.066
Criterion for Iobs, N(hkl)gt: Iobs > 2σ(Iobs), 3,533
N(param)refined: 344
Programs: Rigaku, 1 Olex2, 2 Shelx 3

2 Experimental details

All H atoms attached to carbon were included using a riding-model using Olex2, 1 with C–H = 0.93 Å, and their Uiso values were set to 1.2 Ueq

3 Comment

The title compound, (1Z, 2Z)-3-phenyl-2-propenal 2-(4-bromo-2-fluorophenyl) hydrazone, was designed and synthesized by using the principle of active group splicing. To the best of the asymmetric unit of the title structure contains two (1Z, 2Z)-3-phenyl-2-propenal 2-(4-bromo-2-fluorophenyl) hydrazone molecule. The bond lengths and angles within the structure of 1(1Z, 2Z)-3-phenyl-2-propenal 2-(4-bromo-2-fluorophenyl)hydrazone are unexceptional and lie within the expected ranges. 4 , 5 In details, the N2–C7 distance is 1.283(5) Å and the N4–C22 distance is 1.279(4) Å, which suggests a N=C double bond. It shows that the condensation reaction between the raw materials has produced a hydrazone. Cinnamaldehyde, a well-known natural product, is the main component of the volatile oil with unique flavor. Hydrazone compounds not only have diverse structures, but also have rich biological activities. At the same time, hydrazone compounds also have the advantages of simple preparation and low toxicity. 6 So far, researchers have successfully developed some fungicides, such as Benquinox and Ferimzone. These compounds play corresponding roles mainly by inhibiting different enzymes in cell activities. 7 The title compound is obtained by combining two active structural units, cinnamaldehyde and phenylhydrazone, by using the principle of active group splicing. 8


Corresponding author: Pengfei Ding, Taizhou Polytechnic College, College of Intelligent Pharmaceutical and Chemical New Materials, No. 8 Tianxing Road, Taizhou Medical High Tech Zone, Taizhou, Jiangsu 225300, P.R. China, E-mail:

  1. Conflict of interest: The authors declare no conflicts of interest regarding this article.

  2. Author contribution: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  3. Research funding: The work was supported by General Project for Natural Science Research in Jiangsu Province Universities (24KJD210004), Science and Technology Support Program Project of Taizhou (Agriculture, Social Development) (TS202323).

References

1. Mishra, N. K.; Bansal, D.; Supriya, S. Polyoxometalate-Supported Copper(I)-Pyrazole Complex: Unusual Stability, Geometrical Isomers, Organic Transformation, and Computation. ACS Omega 2022, 7 (35), 31403–31412; https://doi.org/10.1021/acsomega.2c03795.Suche in Google Scholar PubMed PubMed Central

2. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. Olex2: A Complete Structure Solution, Refinement and Analysis Program. J. Appl. Cryst. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar

3. Puschmann, H.; Bourhis, L. J.; Dolomanov, O. V.; Gildea, R. J.; Howard, J. A. K. Olex2 – A Complete Package for Molecular Crystallography. Acta Crystallogr. A 2011, 67, C593; https://doi.org/10.1107/s0108767311084996.Suche in Google Scholar

4. Zoller, T.; Breuilles, P.; Uguen, D.; De Cian, A.; Fischer, J. An Unexpected Sequel of an Alcohol Oxidation Study: Stereoselective Cyclisation of an Unsaturated Keto-Sulfide. Tetrahedron Letters 1999, 40, 6253; https://doi.org/10.1016/S0040-4039(99)01298-8.Suche in Google Scholar

5. Yin, Z.-G.; Qian, H.-Y.; Chen, Y.-Z.; Feng, Y.-L.; 1-(2,4-Dinitrophenyl)-2-(3-phenylallylidene)hydrazine pyridine hemisolvate. Acta Crystallographica Section E: Structure Reports Online 2007, 63, o4625. https://doi.org/10.1107/S1600536807055444.Suche in Google Scholar

6. Goff, G. L.; Ouazzani, J. Natural Hydrazine-Containing Compounds: Biosynthesis, Isolation, Biological Activities and Synthesis. Bioorg. Med. Chem. 2014, 22 (23), 6529–6544; https://doi.org/10.1016/j.bmc.2014.10.011.Suche in Google Scholar PubMed

7. Verma, S.; Lal, S.; Narang, P.; Sudhakar, K. Quinoline Hydrazide/Hydrazone Derivatives: Recent Insights on Antibacterial Activity and Mechanism of Action. ChemMedChem 2023, 18, e202200571; https://doi.org/10.1002/cmdc.202200571.Suche in Google Scholar PubMed

8. Denng, Y.; Chen, M. H.; Yi, J. M.; Zheng, Y. G. Design, Synthesis, and Anti-Tobacco Mosaic Virus Activity Evaluation of Quinazolinone Derivatives Containing Purine Moieties. Phytochem. Lett. 2024, 59, 10–14; https://doi.org/10.1016/j.phytol.2023.11.003.Suche in Google Scholar

Received: 2025-01-13
Accepted: 2025-09-27
Published Online: 2025-10-23
Published in Print: 2025-12-17

© 2025 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of (1Z, 2Z)-3-phenyl-2-propenal 2-(4-bromo-2-fluorophenyl)hydrazone, C15H12BrFN2
  4. Refinement of crystal structure of 2-(2,3-dihydro-3-oxo-1 H -inden-1-ylidene)-1 H -indene-1,3(2 H )-dione C18H10O3
  5. The crystal structure of 3-(1-fluoro-2-(naphthalen-2-yl)-2-oxoethyl)-2-methoxy-3,4-dihydroisoquinolin-1(2H)-one, C22H18FNO3
  6. Crystal structure of the dinuclear copper(II) complex bis(μ2-2,2′ -{[1,3-phenylenebis-(methylene)]bis(oxy)}dibenzoaot-κ4O,O′:O′′,O′′′)-bis(dimethylformamide-κ1O)dicopper(II), C50H44Cu2N2O14
  7. Crystal structure of poly[triaqua-(μ9-biphenyl-3,3′,5,5′-tetracarboxylic-κ8 O,O:O,O′: O,O″:O,O‴)samarium(III)sodium(I)], C16H12NaSmO11
  8. The crystal structure of 5-benzyl-1-(4-fluorobenzyl)-4-((4-fluorobenzyl)oxy)-1,5-dihydro-2H-pyrrol-2-one, C25H21F2NO2
  9. The crystal structure of diammonium 2,5-dihydroxyterephthalate, C8H12N2O6
  10. Crystal structure of (E)-4-(4-(1H-1,2,4-triazol-1-yl)benzylidene)-6,8-dimethoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one, C21H19N3O4
  11. Crystal structure of poly[oktakis(μ2-oxido-κ2O:O)-tetrakis(oxido-κ1O)-bis(μ2-1,1′-[1,4-phenylenebis(methylene)]di(1H-imidazole-κ2N:N′))-tetravanadium(V)-dizinc(II)] monohydrate, C28H30Zn2N8O13V4
  12. Crystal structure of acotiamide hydrochloride dimethylacetamide solvate (1/1), C25H40ClN5O6S
  13. Crystal structure of catena-poly[monoaqua (u2-(3-(3,5-dicarboxyphenyl)pyridine-2,6-dicarboxylic-k4O:O′:O″:N)zinc(II))] monohydrate, C15H11NO10Zn
  14. Crystal structure of dichlorido{2,6-bis(3,5-diisopropyl-N-pyrazolyl)pyridine}zinc(II), C23H33Cl2N5Zn
  15. Crystal structure of nitrato-κ2O,O′-[hydridotris(3,5-diethylpyrazol-1-yl)borato-κ3N,N′,N″]copper(II), C21H34BCuN7O3
  16. Crystal structure of 2,7-bis(3,5-diethyl-1H-pyrazol-4-yl)-benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone, C28H26N6O4
  17. Crystal structure of 2-(4-chlorophenyl)benzothiazole, C13H8ClNS
  18. Synthesis and crystal structure (3R,4′S)-4′-(3,5-dibromophenyl)-1′-methyl-2H-dispiro [benzofuran-3,3′-pyrrolidine-2′,2″-indene]-1″,2,3″-trione, C26H17Br2NO4
  19. Crystal structure of bis(((3a,7a-dihydro-1H-benzo[d][1,2,3]triazol-1-yl)methyl) triphenylphosphonium) tetrachloridomanganate(II), C50H42Cl4MnN6P2
  20. The crystal structure of 4,9-bis(4-chlorophenyl)-1,6-bis(2-cyanobenzyl)-2,4a,5,6,7,7a-hexahydro-1H-2,7,5-(epiprop[2]ene[1,1,3]triyl)pyrrolo[3,4-b]pyridine-3,10-dicarbonitrile, C40H26Cl2N6
  21. The crystal structure of poly((μ2-3-(3-nitro-4-carboxylphenyl)benzoate-κ3O, O′:O″)-μ2-1,4-bis(1-imidazolyl)benzene-κ2N:N′-cadmium(II)), C26H17N5O6Cd
  22. The crystal structure of 6-hydroxy-5H-pyrrolo[3,4-b]pyridine-5,7(6H)-dione monohydrate, C7H6N2O4
  23. Crystal structure of 4-((cyclohexylsulfonyl)methyl)-1,2,3,4-tetrahydrobenzo [4,5]imidazo[1,2-a]pyridine, C18H24N2O2S
  24. Crystal structure of 4,7-diphenyl-1,10-phenanthroline-κ2N,N′)-bis(2,4-di(fluorine)-1-phenylpyridine-κ2C,N)-iridium(III) hexafluorophosphate–dichloromethane (1/1), C47H30Cl2F10IrN4P
  25. Crystal structure of (4-(1-phenyl-1H-benzo[d]imidazol-2-yl)phenyl)boronic acid, C19H15BN2O2
  26. The crystal structure of (E)-(2-((pyridin-2-ylmethylene)amino)phenyl)arsonic acid, C12H11AsN2O3
  27. The crystal structure of N(benzyl(phenyl)carbomothioyl)benzamide, C21H18N2OS
  28. The crystal structure of bis(2-picolinium) hexachlorostannate dichloromethane monosolvate, C13H18Cl8N2Sn
  29. Crystal structure of poly[tetraaqua-bis(μ4-3–1-(carboxylatomethyl)-1H-1,2,4-triazole-3-carboxylato)-κ4O:O′,O″,N)zinc(II)], C5H7N3O6Zn
  30. The crystal structure of the co-crystal isonicotinamide – 2-(nitrophenyl)methanol (1/1), C6H6N2O·C7H7NO3
  31. The crystal structure of 4-(3-carboxy-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)piperazin-1-ium 2-fluorobenzoate hydrate, C23H25F2N3O6
  32. Crystal structure of [diaqua-{1H-benzo[d]imidazol-3-ium-5,6-dicarboxylato-κ2O,O′}magnesium(II)] C18H14MgN4O10
  33. Crystal structure of (3-(dimethoxymethyl)-5-methoxy-1H-indol-1-yl) (2-iodo-5-methoxyphenyl)methanone, C20H20INO5
  34. The crystal structure of 3,7,11-trimethylbenzo[5,6][1,4]thiazino[2,3,4-kl]phenothiazine 5,5,9,9-tetraoxide, C21H17NO4S2
  35. Crystal structure of tris(piperazine-1,4-diium)bis(2-hydroxy-1,2,3-propane-tricarboxylate) pentahydrate, C24H56N6O19
  36. Crystal structure of 2-chloro-5-((5-isopropyl-2-methylphenoxy)methyl)pyridine, C16H18ClNO
  37. Crystal structure of (E)-4-(4-(1H-pyrrol-1-yl)benzylidene)-6,8-dimethoxy-3,4-dihydrobenzo[(b)]oxepin-5(2H)-one, C23H21NO4
  38. Crystal structure of (E)-N′-(3,4-dichlorobenzylidene)-3,4,5-trimethoxybenzohydrazide, C17H16Cl2N2O4
  39. The crystal structure of 2-(2-hydroxyphenyl)-3-(pyridin-2-yl)-2,3- dihydroquinazolin-4(1H)-one, C19H15N3O2
  40. Crystal structure of 5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-8-methylchroman-4-one, C17H16O5
  41. Crystal structure of bis[(3,4-dimethoxybenzyl)triphenylphosphonium]di-μ2-bromido-dibromidodicopper(I)
  42. Crystal structure of bis [(1,3-dioxolan-2-ylmethyl)triphenylphosphonium] tetrabromidodicopper(I), C22H22Br2CuO2P
  43. Crystal structure of [1-(4-carboxyphenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylic acid], C12H8N2O5
  44. The crystal structure of one-dimensional cooridnation polymer bis(thiocyanato)-bis((1E,2E)-1,2-bis(1-(pyridin-3-yl)ethylidene)-hydrazine κ2N:N)iron(II), (C30H28N10S2Fe)n
  45. Crystal structure of ((4-acetamidophenyl)sulfonyl)-l-alanine, C11H14N2O5S
  46. Crystal structure of [(1-naphthalen-1-yl-methyl)triphenylphosphonium] dichloridocopper(I), [C29H24P]+[CuCl2]
  47. RbTm3S5: the first rubidium lanthanoid(III) sulfide with CsEr3Se5-type crystal structure
  48. Crystal structure of 2,2′-((ethane-1,2-diylbis(methylammoniumdiyl))bis(methylene))bis(pyridin-1-ium) diiodido-tris(μ2-iodido-κ2I:I)dicopper(II) chloride dihydrate, C16H30Cu2I6N4O2
  49. The crystal structure of 4-(trifluoromethyl)pyridine-2-carboxylic acid, C7H4F3NO2
  50. The crystal structure of (E)-2-ethoxy-1-methoxy-4-(2-(methylsulfonyl)vinyl)benzene, C12H16O4S
  51. Crystal structure of potassium 1H,1H,2H,2H-perfluorooctanesulfonate, C8H4O3F13SK
  52. Crystal structure of 4-(4-(quinolin-8-yloxy)-1,2,5-thiadiazol-3-yl)morpholine, C15H14O2N4S
  53. The crystal structure of 1,4-bis(bromomethyl)-2,5-dimethylbenzene, C10H12Br2
  54. The crystal structure of imidazo[4,5-e][1,3]diazepine-4,6,8-triamine methanol solvate, C7H11N7O
  55. The crystal structure of chlorido-bis(1,10-phenantroline-κ2N,N′)-(2-formylphenoxyacetato-κ2O,O) lead(II), C33H23N4O4ClPb
  56. Crystal structure of pyridinium tetrakis(1,1,1-trifluoro-2,4-pentadionato-κ2O,O′)yttrium(III) C20F12H16YO8C5H6N
Heruntergeladen am 10.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2025-0027/html
Button zum nach oben scrollen